Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
BMC Infectious Diseases|March 7, 2020
Efficacy and tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected patients with psychiatric disordersNicolò de Gennaro, Lucia Diella, Laura Monno, et al.
Antibiotics (Basel, Switzerland)|March 25, 2022
Meropenem/Vaborbactam Plus Aztreonam as a Possible Treatment Strategy for Bloodstream Infections Caused by Ceftazidime/Avibactam-Resistant Klebsiella pneumoniae: A Retrospective Case Series and Literature ReviewAlessandra Belati, Davide Fiore Bavaro, Lucia Diella, et al.
Infectious Diseases (London, England)|December 9, 2020
Recurrent neurosurgical site infection by extensively drug-resistant P. aeruginosa treated with cefiderocol: a case report and literature reviewDavide Fiore Bavaro, Federica Romanelli, Stefania Stolfa, et al.
Journal of Forensic and Legal Medicine|September 26, 2024
Beyond the distance between juridic and scientific decision-making process: An evidence-based prediction algorithm for professional liability assessment in healthcare-associated infectionsSara Sablone, Andrea Nicola Cardinale, Ettore Gorini, et al.
Expert Opinion on Drug Safety|December 25, 2023
Safety and effectiveness of fifth generation cephalosporins for the treatment of methicillin-resistant staphylococcus aureus bloodstream infections: a narrative review exploring past, present, and futureDavide Fiore Bavaro, Alessandra Belati, Linda Bussini, et al.
Le Infezioni in Medicina|June 13, 2022
Thoracic aorta graft infection by avibactam-resistant KPC-producing K. pneumoniae treated with meropenem/vaborbactam: a case report and literature reviewAlessandra Belati, Roberta Novara, Davide Fiore Bavaro, et al.
Current Issues in Molecular Biology|December 27, 2024
Updates on the Activity, Efficacy and Emerging Mechanisms of Resistance to CefiderocolGabriele Bianco, Matteo Boattini, Monica Cricca, et al.
Frontiers in Public Health|January 23, 2023
Analysis of Italian requests for compensation in cases of responsibility for healthcare-related infections: A retrospective studyMaricla Marrone, Pierluigi Caricato, Federica Mele, et al.
Expert Review of Hematology|April 3, 2023
Current therapies for chronic lymphocytic leukemia: risk and prophylaxis strategies for secondary/opportunistic infectionsLucia Diella, Davide Fiore Bavaro, Giacomo Loseto, et al.
Viruses|August 26, 2023
What Is the Efficacy of Sotrovimab in Reducing Disease Progression and Death in People with COVID-19 during the Omicron Era? Answers from a Real-Life StudyAndrea De Vito, Agnese Colpani, Mariacristina Poliseno, et al.
Pageof 4